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Regulation Of Cell Death Apoptotic Pathways By
Nitric Oxide In Cancer: Reversal Of Drug/Immune
Resistance
Benjamin Bonavida
Jonsson Comprehensive Cancer Center, University of California, Los
Angeles, USA
Tumor cells develop several mechanisms to avoid cell death
by various unrelated cytotoxic agents. We have identiﬁed one
such gene regulatory mechanism that inhibits, in large part, the
cell death apoptotic pathways. This dysregulated mechanism
is the result of several inter-related gene products that form a
loop and consist of the NF-κB/Snail/YY1/RKIP/PTEN. The gene
product expressions in this loop regulate the resistance to both
chemotherapeutic drugs and cytotoxic immune lymphocytes/
ligands. Brieﬂy, the expressions and activities of NF-κB, Snail
and YY1 are upregulated whereas the expressions and the
activities of RKIP and PTEN are downregulated. The upregulated
gene products are involved in the cell survival and growth and
the expression of anti-apoptotic gene products; however, the
downregulated gene products are involved in the inhibition of
cell survival and anti-apoptotic gene products. The modulation of
each of the gene products in the loop is sufﬁcient to reverse
resistance. We have found that treatment of tumor cells with
high levels of NO donors resulted in the downregulation of the
expression of NF-κB, Snail and YY1 while upregulation of RKIP
and PTEN. Treatment with NO inhibited NF-κB, Snail and YY1 via
s-nitrosylation. As repressors, their inhibition resulted in the
upregulation of RKIP and PTEN. Subsequently, several anti-apop-
totic gene products are inhibited by NO treatment as well as
modifying the integrity of the mitochondria. Hence, treatment of
resistant tumor cells with NO resulted in both the chemo and
immunosensitization of tumor cells to apoptosis, in vitro and
in vivo. The ﬁndings suggested the important role of NO donors
as potential therapeutic sensitizing agents to reverse resistance.
http://dx.doi.org/10.1016/j.redox.2015.09.016
Role Of S-Nitrosylation In The Extrinsic Apoptotic
Signalling Pathway In Cancer
Stéphanie Plenchette
Laboratoire d’Immunologie et Immunothérapie des Cancers, EPHE-
Université de Bourgogne EA 7269, Faculté de Médecine, Dijon, France
One of the key features of tumour cells is the acquisition of
resistance to apoptosis. Thus, determining therapeutic strategies
that circumvent apoptotic resistance and result in tumor regres-
sion is a challenge. One strategy to induce apoptosis is to activate
death receptor signalling pathways. Members of the Tumor
Necrosis Factor TNF-family death receptors ligand (TRAIL, FasL
and TNF-α) can originate from immune and non-immune cells.
Death receptors, engaged by cognate ligands, can initiate multiple
signaling pathways, which can generate diverse outcomes,
including non-apoptosis-related signal. Knowledge on the mole-
cular mechanisms (that determine death or survival of tumour
cells) following exposure to the TNF-family death receptors
ligands have demonstrated that post-translational modiﬁcations
of the signaling pathway components play a critical role in
determining cell fate. Cell death can be sensed by nitric oxide
(NO) in a wide variety of tumour cells. S-nitrosylation, the covalent
modiﬁcation of a protein cysteine thiol by an NO moiety, has
emerged as an important post-translational regulation for the
TNF-family death receptor signaling pathways. It has been demon-
strated that death receptor DR4 (TRAIL-R1) becomes S-nitrosy-
lated and promotes apoptosis following a speciﬁc NO donor
treatment (Tang et al., 2006). Then, our group has shown that
S-nitrosylation of Fas, following glyceryl trinitrate (GTN) exposure,
promotes redistribution of the receptor to lipid rafts, formation of
the death-inducing signal complex (DISC), and induction of cell
death. Finally, I will discuss our recent efforts to decipher regula-
tory mechanism of the TNF-α/TNFR1 signalling cell death pathway
by S-nitrosylation following GTN treatment.
http://dx.doi.org/10.1016/j.redox.2015.09.017
Synergistic Interactions Between Nitric Oxide And
Reactive Oxygen Species Cause Selective Apoptosis
Induction In Malignant Cells
Georg Bauer
Institute of Virology, Department of Medical Microbiology and
Hygiene, University Medical Center, Freiburg, Germany
Background: Oncogenic transformation depends on the activation
of membrane-associated NADPH oxidase. The resultant extracel-
lular superoxide anions control the proliferation of malignant cells,
but they also drive two intercellular signaling pathways that cause
selective apoptosis induction in malignant cells, i. e. the HOCl and
the NO/peroxynitrite pathway. Tumor progression requires the
establishment of resistance against these apoptosis-inducing path-
ways through expression of membrane-associated catalase that
interferes with HOCl signaling through decomposition of H2O2 and
with NO/peroxynitrite through oxidation of NO and decomposi-
tion of peroxynitrite.
Aims: We aimed to establish the biochemical basis for novel
therapeutic approaches that target tumor cell protective catalase
and thus cause reactivation of intercellular reactive oxygen/nitro-
gen species-dependent apoptotic signaling of tumor cells.
Methods: We used cells from deﬁned stages of multistep oncogen-
esis, i. e. nontransformed, transformed and bona vide tumor cells.
Intercellular apoptosis-inducing ROS/RNS signaling was studied
using deﬁned inhibitors/scavengers, reconstitution experiments
and small interfering RNA directed against relevant targets.
Results: Direct inhibition of tumor cell catalase by neutralizing
antibodies or its direct inactivation by extracellular singlet oxygen
caused efﬁcient reactivation of apoptosis-inducing signaling. Inter-
estingly, the increase in cell-derived NO through addition of
arginine, inhibition of arginase, inhibition of NO dioxygenase or
induction of NO synthase by interferon led to the generation of
extracellular singlet oxygen that triggered a complex self-ampliﬁ-
catory system. As a result, high concentrations of cell-derived
singlet oxygen inactivated catalase and reactivated apoptosis
inducing intercellular signaling.
V. Rapozzi et al. / Redox Biology 5 (2015) 413–423 415
Conclusions: Modulation of the cellular NO concentration causes





Detection Of Human Papilloma Virus (Type 16 And
18) In Cytological Samples In Patients With Lung
Cancer. An Evaluation By Chromogenic In Situ Hybri-
dization Technique
Nada Al-Shabbani
Al Karama Teaching Hospital, Baghdad, Iraq
Background: Lung cancer is a common neoplasm. Some studies
suggested that HPV may play an etiologic role in bronchial
carcinogenesis and possibility of a latent HPV infection as a
cocarcinogen cannot be excluded. HPV (high risk types) 16 &18
may affect the cell cycle and inhibit apoptosis, allowing uncon-
trolled cell division.
Aims of study: 1. To use bronchial wash as a non invasive
procedure to determine the presence of DNA of high risk types
(16 &18 )of HPV in patients with lung cancer using in situ
hybridization technique. 2. To Find the association of the score
or intensity of viral in situ hybridization signals with histopatho-
logical types.
Patients, Materials and methods: A prospective study, whereby
bronchial wash of 50 patients diagnosed cytologicaly as having
lung cancer together with samples from 30 patient having chronic
illness as control.
Results: The most affected age group was 66–70 years (28% of the
cases). Males were affected more frequently than females (64.0%).
Regarding HPV16 & 18 and histological types of lung cancer the
commonest effected type was squamouse cell carcinoma showed
positive signals in 32% and 28% for HPV16&HPV18 respectively.
Percentage score and intensity score: Lung cancer samples showed
low intensity signals for human papilloma virus16 in 63.6% of
samples and 44.5% for human papilloma virus 18.
Conclusions: Human papilloma virus 16 and 18 was detected in
cytological bronchial samples of patients with lung cancer in
relatively high percentage
http://dx.doi.org/10.1016/j.redox.2015.09.019
Stabilization Of Apoptotic Cells: Generation Of Zom-
bie Cells
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Elisabet Alcocer Gómez, Antonio Rodríguez Moreno
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Apoptosis is characterized by degradation of cell components
but plasma membrane remains intact. Apoptotic microtubule
network (AMN) is organized during apoptosis forming a cortical
structure beneath plasma membrane that maintains plasma
membrane integrity. Apoptotic cells are also characterized by high
reactive oxygen species (ROS) production that can be potentially
harmful for the cell. The aim of this study was to develop a method
that allows stabilizing apoptotic cells for diagnostic and therapeutic
applications. We were able by using a cocktail composed of taxol (a
microtubule stabilizer), Zn2+ (a caspase inhibitor) and coenzyme Q10
(a lipid antioxidant) to stabilize H460 apoptotic cells in cell cultures
for at least 72 hours preventing secondary necrosis. Stabilized
apoptotic cells maintain many apoptotic cells characteristics such as
the presence of apoptotic microtubules, plasma membrane integrity,
low intracellular calcium levels, plasma membrane potential, PS
externalization and ability of being phagocytosed.
Stabilized apoptotic cells can be considered as dying cells in
which the cellular cortex and plasma membrane are maintained
intact or alive. In a metaphorical sense, we can consider them as
“living dead” or “zombie cells”.
Stabilization of apoptotic cells can be used for reliable detection
and quantiﬁcation of apoptosis in cultured cells and may allow a
safer administration of apoptotic cells in clinical applications.
Furthermore, it opens new avenues in the functional reconstruction
of apoptotic cells for longer preservation.
http://dx.doi.org/10.1016/j.redox.2015.09.020
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STAT3 Regulation By S-Nitrosylation: Implication In
Cancer
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In this study, we assessed S-nitrosylation-based regulation of
Janus-activated kinase 2/signal transducer and activator of tran-
scription 3 (JAK2/STAT3) pathway. Our studies show that STAT3 in
stimulated microglia underwent two distinct redox-dependent
modiﬁcations, S-nitrosylation and S-glutathionylation. STAT3
S-nitrosylation was associated with inducible nitric oxide synthase
(iNOS)-produced nitric oxide (NO) and S-nitrosoglutathione
(GSNO), whereas S-glutathionylation of STAT3 was associated with
cellular oxidative stress. NO produced by iNOS or treatment of
microglia with exogenous GSNO inhibited STAT3 activation via
inhibiting STAT3 phosphorylation (Tyr705). Consequently, the
interleukin-6 (IL-6)-induced microglial proliferation and asso-
ciated gene expressions were also reduced. In cell-free kinase
assay using puriﬁed JAK2 and STAT3, STAT3 phosphorylation was
inhibited by its selective preincubation with GSNO, but not by
preincubation of JAK2 with GSNO, indicating that GSNO-mediated
mechanisms inhibit STAT3 phosphorylation through S-nitrosyla-
tion of STAT3 rather than JAK2. In this study, we identiﬁed that
Cys259 was the target Cys residue of GSNO-mediated S-nitrosyla-
tion of STAT3. The replacement of Cys259 residue with Ala
abolished the inhibitory role of GSNO in IL-6-induced STAT3
phosphorylation and transactivation, suggesting the role of
Cys259S-nitrosylation in STAT3phosphorylation.
V. Rapozzi et al. / Redox Biology 5 (2015) 413–423416
